338 related articles for article (PubMed ID: 29920909)
1. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
3. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
4. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
[TBL] [Abstract][Full Text] [Related]
5. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
[TBL] [Abstract][Full Text] [Related]
7. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP
Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531
[TBL] [Abstract][Full Text] [Related]
10. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
11. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
[TBL] [Abstract][Full Text] [Related]
12. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
14. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer.
Khan MAS; Ang CW; Hakeem AR; Scott N; Saunders RN; Botterill I
J Gastrointest Surg; 2017 Dec; 21(12):2056-2065. PubMed ID: 28924962
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
17. The role of pelvic exenteration in the management of recurrent rectal cancer.
Kakuda JT; Lamont JP; Chu DZ; Paz IB
Am J Surg; 2003 Dec; 186(6):660-4. PubMed ID: 14672775
[TBL] [Abstract][Full Text] [Related]
18. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases].
Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M
Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298
[TBL] [Abstract][Full Text] [Related]
19. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
[TBL] [Abstract][Full Text] [Related]
20. Pelvic resection of recurrent rectal cancer.
Wanebo HJ; Koness RJ; Vezeridis MP; Cohen SI; Wrobleski DE
Ann Surg; 1994 Oct; 220(4):586-95; discussion 595-7. PubMed ID: 7524455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
